Surgical Science Sweden - Stock

Surgical Science Sweden Equity 2024

Surgical Science Sweden Equity

4.35 B SEK

Ticker

SUS.ST

ISIN

SE0014428512

WKN

A2P46G

In 2024, Surgical Science Sweden's equity was 4.35 B SEK, a 2.57% increase from the 4.24 B SEK equity in the previous year.

Surgical Science Sweden Aktienanalyse

What does Surgical Science Sweden do?

Surgical Science Sweden AB is a Swedish company specializing in the development and manufacturing of medical simulators for training professionals in the medical industry. The company was founded in 1999 by a team of doctors, engineers, and scientists and is headquartered in Gothenburg. Since then, the company has constantly expanded and now has several branches around the world, including in the USA, Germany, and Hong Kong. Due to its innovative products and high-quality standards, the company is globally recognized and has received numerous awards. Surgical Science Sweden AB offers a wide range of simulators for various medical disciplines, including surgery, anesthesia, obstetrics, and pediatrics. They offer both hardware and software-based solutions that allow trainees to practice complex procedures and interventions in a safe environment. The company's business model is based on the belief that simulation is crucial for the training of medical professionals to ensure the highest quality and safety for patients. By simulating realistic situations, trainees can gain valuable experience before working in the real practice. Surgical Science Sweden AB has a range of products targeting various areas of medical education. One of their most well-known simulators is the LaparoSculptor, which was specifically developed for training in minimally invasive surgery. The simulator can perform various procedures such as gallbladder and hernia operations, offering both physical and virtual options. Another product is the ObstetricSim, a simulator for obstetric training. The simulator fully simulates the conditions of a normal birth, including the stages of labor and delivery. It also includes rare complications such as shoulder dystocia and umbilical cord prolapse. Surgical Science Sweden AB has also developed simulators focusing on the training of anesthesiologists. The simulator in this area is the ANTS (Anesthesia Simulator), which trains trainees in the proper use of anesthetics, patient observation, and managing emergencies during anesthesia issues. In addition to developing hardware and software solutions, the company also focuses on continuous improvement and development of its products. Surgical Science Sweden AB works closely with leading medical specialists to ensure that the simulator meets the latest requirements and best practices. The company is also willing to rent or sell the simulators and its expertise to medical institutions, providing a broader audience with the opportunity to benefit from the technology. In conclusion, Surgical Science Sweden AB makes a significant contribution to the training of medical professionals and thereby contributes to improving patient health worldwide with its innovative and high-quality simulators. By combining the latest technology, industry expertise, and a constant focus on customer needs, the company continuously strives for excellence and innovation. Surgical Science Sweden ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Surgical Science Sweden's Equity

Surgical Science Sweden's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Surgical Science Sweden's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Surgical Science Sweden's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Surgical Science Sweden's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Surgical Science Sweden’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Surgical Science Sweden Stock

What is the equity of Surgical Science Sweden this year?

Surgical Science Sweden has equity of 4.35 B SEK this year.

What was the equity of Surgical Science Sweden compared to the previous year?

The equity of Surgical Science Sweden has increased/decreased by 2.57% increased compared to the previous year.

What impact does a high equity have on investors of Surgical Science Sweden?

A high equity is advantageous for investors of Surgical Science Sweden as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Surgical Science Sweden?

A low equity can be a risk for investors of Surgical Science Sweden, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Surgical Science Sweden affect the company?

An increase in equity of Surgical Science Sweden can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Surgical Science Sweden affect the company?

A reduction in equity of Surgical Science Sweden can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Surgical Science Sweden?

Some factors that can affect the equity of Surgical Science Sweden include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Surgical Science Sweden so important for investors?

The equity of Surgical Science Sweden is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Surgical Science Sweden take to change the equity?

To change equity, Surgical Science Sweden can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Surgical Science Sweden pay?

Over the past 12 months, Surgical Science Sweden paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Surgical Science Sweden is expected to pay a dividend of 0 SEK.

What is the dividend yield of Surgical Science Sweden?

The current dividend yield of Surgical Science Sweden is .

When does Surgical Science Sweden pay dividends?

Surgical Science Sweden pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Surgical Science Sweden?

Surgical Science Sweden paid dividends every year for the past 0 years.

What is the dividend of Surgical Science Sweden?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is Surgical Science Sweden located?

Surgical Science Sweden is assigned to the 'Health' sector.

Wann musste ich die Aktien von Surgical Science Sweden kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Surgical Science Sweden from 6/18/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 6/18/2024.

When did Surgical Science Sweden pay the last dividend?

The last dividend was paid out on 6/18/2024.

What was the dividend of Surgical Science Sweden in the year 2023?

In the year 2023, Surgical Science Sweden distributed 0 SEK as dividends.

In which currency does Surgical Science Sweden pay out the dividend?

The dividends of Surgical Science Sweden are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Surgical Science Sweden

Our stock analysis for Surgical Science Sweden Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surgical Science Sweden Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.